Skip to content
10-Q

Quarterly Report

BIOCANCELL THERAPEUTICS INC.

0001178913-11-002975

← back to feed
Filed
Nov 7, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 6, 2011 26.69M sh
Shares Diluted Q3 2011 · Sep 30, 2011 26.68M sh
Shares Diluted Q3 2011 · Sep 30, 2011 26.52M sh
Shares Diluted Q3 2011 · Sep 30, 2011 13.68M sh
Shares Diluted Q3 2011 · Sep 30, 2010 20.64M sh
Shares Diluted Q3 2011 · Sep 30, 2010 19.49M sh
Stock Repurchased Q3 2011 · Sep 30, 2011 $4.95M
Capex Q3 2011 · Sep 30, 2011 $14K
Capex Q3 2011 · Sep 30, 2011 $237K
Capex Q3 2011 · Sep 30, 2010 $8K
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$3.74M
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$21.8M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$2.24M
Cash And Equivalents Q3 2011 · Sep 30, 2011 $1.79M
Cash And Equivalents Q3 2011 · Dec 31, 2010 $3.49M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $1.48M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $624K
Stockholders Equity Q3 2011 · Sep 30, 2011 −$1.48M
Stockholders Equity Q3 2011 · Dec 31, 2010 $2.1M
Current Liabilities Q3 2011 · Sep 30, 2011 $3.28M
Current Liabilities Q3 2011 · Dec 31, 2010 $1.13M
Current Assets Q3 2011 · Sep 30, 2011 $2.18M
Current Assets Q3 2011 · Dec 31, 2010 $5.7M
Total Assets Q3 2011 · Sep 30, 2011 $2.87M
Total Assets Q3 2011 · Dec 31, 2010 $6.11M
Eps Diluted Q3 2011 · Sep 30, 2011 −$0.04
Eps Diluted Q3 2011 · Sep 30, 2011 −$0.15
Eps Diluted Q3 2011 · Sep 30, 2011 −$1.80
Eps Diluted Q3 2011 · Sep 30, 2010 −$0.08
Eps Diluted Q3 2011 · Sep 30, 2010 −$0.09
Eps Basic Q3 2011 · Sep 30, 2011 −$0.04
Eps Basic Q3 2011 · Sep 30, 2011 −$0.15
Eps Basic Q3 2011 · Sep 30, 2011 −$1.75
Eps Basic Q3 2011 · Sep 30, 2010 −$0.08
Eps Basic Q3 2011 · Sep 30, 2010 −$0.09
Sga Expense Q3 2011 · Sep 30, 2011 $466K
Sga Expense Q3 2011 · Sep 30, 2011 $1.57M
Sga Expense Q3 2011 · Sep 30, 2011 $9.82M
Sga Expense Q3 2011 · Sep 30, 2010 $402K
Sga Expense Q3 2011 · Sep 30, 2010 $1.3M
Rd Expense Q3 2011 · Sep 30, 2011 $991K
Rd Expense Q3 2011 · Sep 30, 2011 $2.64M
Rd Expense Q3 2011 · Sep 30, 2011 $16.12M
Rd Expense Q3 2011 · Sep 30, 2010 $374K
Rd Expense Q3 2011 · Sep 30, 2010 $1.39M
Net Income Q3 2011 · Sep 30, 2011 −$1.12M
Net Income Q3 2011 · Sep 30, 2011 −$4.01M
Net Income Q3 2011 · Sep 30, 2011 −$23.32M
Net Income Q3 2011 · Sep 30, 2010 −$1.57M
Net Income Q3 2011 · Sep 30, 2010 −$1.85M
Operating Income Q3 2011 · Sep 30, 2011 −$1.36M
Operating Income Q3 2011 · Sep 30, 2011 −$3.88M
Operating Income Q3 2011 · Sep 30, 2011 −$23.2M
Operating Income Q3 2011 · Sep 30, 2010 −$604K
Operating Income Q3 2011 · Sep 30, 2010 −$2.29M
Short Term Investments Q3 2011 · Dec 31, 2010 $1.99M